Fenspiride
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Drug/Substance Trade Name(S)
- (12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
- Supplementary Figure Legends Figure S1. Azelastine Inhibits the Proliferation of CRC Cells with No Toxic Effects in Mice. (A) Co
- Interactions Pharmacokinetics Profile Uses and Administration
- 11-14 February 2019 PRAC Meeting Minutes
- PRAC Draft Agenda of Meeting 11-14 February 2019
- 13-16 May 2019 PRAC Meeting Minutes
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Pre- and Postjunctional Inhibitory Effects of Fenspiride on Guinea-Pig Bronchi
- Uniform Classification Guidelines for Foreign Substances, Version 7.00
- Marrakesh Agreement Establishing the World Trade Organization
- (12) United States Patent (10) Patent No.: US 8,506,935 B2 Hale Et Al
- Acetaminophen + Ascorbic Acid + Pheniramine + Phenylephrine Acetaminophen + Chlorpheniramine + Phenylephrine Acetylaminonitropro
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- 2019 Equine Prohibited Substances List
- TEXAS RACING COMMISSION December 1, 2020 To
- 202992Orig1s000